ROBAXISAL C 1/2
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is ROBAXISAL C 1/2 discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that ROBAXISAL C 1/2 325MG 32.4MG 400MG has been permanently discontinued (last updated March 2, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is ROBAXISAL C 1/2 not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
01934791
Strength
325MG 32.4MG 400MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ACETYLSALICYLIC ACID CODEINE PHOSPHATE METHOCARBAMOL
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Business reasons
Disruption of the manufacture of the drug.
Other Products from GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.